DAI Nippon Pharmaceutical revenue for the last year amounted to 2.08 B USD, the most of which — 2.08 B USD — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 3.84 B USD. The greatest contribution to the revenue figure was made by North America — last year it brought DAI Nippon Pharmaceutical 1.05 B USD, and the year before that — 2.47 B USD.